SEC Filing Details

Together with patients, physicians, scientists, and industry partners we are relentlessly focused on rewriting cancer so that a diagnosis is transformed from a foregone conclusion to a more hopeful future

SEC Filing Details

Document Details

Form
Filing Date
Nov 17, 2020
Document Date
Nov 17, 2020
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Five Prime Therapeutics
Issuer
FIVE PRIME THERAPEUTICS, INC.